Wednesday, 31 August 2022
The WHO R&D Blueprint organised this consultation with experts in the field to apply scientific lessons learned during the SARS-CoV-2 global pandemic and draw an outline list of scientific gaps and priority research questions to prepare for pathogens with epidemic and pandemic potential.
Thursday, 10 December 2020
The CoNVaT project dedicated to the development of a fast, cheap, portable and reliable test for the diagnostics of COVID-19, led by Prof. Laura Lechuga, head of the ICN2 NanoBiosensors and Bioanalytical Applications group, has been featured in a news report called “Beyond the vaccine” by RTVE. Broadcast on December 9, this episode of the “Comando Actualidad” programme was dedicated to the research about coronavirus (vaccine, therapy and diagnostics) currently under development in Spain.
Tuesday, 20 October 2020
The prestigious Rei Jaume I Award, sponsored by the Valencian Government (Generalitat Valenciana), is conferred to experts who have significantly contributed to the advancement of their research fields. It recognises the accomplishments in six categories with a golden medal and a 100,000-euro cheque to be used mainly for research and innovation activities. Prof. Laura M. Lechuga Gomez receives the New Technologies Award for her long innovative career in the field of nanobiosensors.
Monday, 05 October 2020
The ICN2 has signed the European Commission Manifesto for maximizing the accessibility of research results in the fight against COVID-19.
Monday, 21 September 2020
In a thorough review recently published in ACS Sensors, researchers from the ICN2 NanoBiosensors and Bioanalytical Applications group, led by Prof. Laura M. Lechuga, provide an overview of the current diagnostic techniques for respiratory viruses, as the SARS-CoV-2, causing agent of COVID-19, and discuss how nanophotonic biosensor technologies can contribute to the development of new fast, highly sensitive and affordable diagnostic tests.
